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Summary
The growing commercial interest in multi-strain for-
mulations marketed as probiotics has not been
accompanied by an equal increase in the evaluation
of quality levels of these biotechnological products.
The multi-strain product VSL#3 was used as a model
to setup a microbiological characterization that could
be extended to other formulations with high com-
plexity. Shotgun metagenomics by deep Illumina
sequencing was applied to DNA isolated from the
commercial VSL#3 product to conﬁrm strains iden-
tity safety and composition. Single-cell analysis was
used to evaluate the cell viability, and b-galactosi-
dase and urease activity have been used as marker
to monitor the reproducibility of the production pro-
cess. Similarly, these lots were characterized in
detail by a metaproteomics approach for which a
robust protein extraction protocol was combined
with advanced mass spectrometry. The results iden-
tiﬁed over 1600 protein groups belonging to all
strains present in the VSL#3 formulation. Of interest,
only 3.2 % proteins showed signiﬁcant differences
mainly related to small variations in strain abun-
dance. The protocols developed in this study
addressed several quality criteria that are relevant
for marketed multi-strain products and these repre-
sent the ﬁrst efforts to deﬁne the quality of complex
probiotic formulations such as VSL#3.
Introduction
The global sales of cultures marketed as probiotics is
increasing every year, and their application is considered
instrumental for improving health and well-being. How-
ever, this growing scientiﬁc and commercial interest has
not been accompanied by an equal increase in the eval-
uation of quality levels for the products that are commer-
cialized (Sanders et al., 2014; Kolace^k et al., 2017). In
contrast to starter cultures that are under a strict microbi-
ological quality control because their activity is funda-
mental for the success of the production process of
industrial fermentations, probiotics are currently only con-
trolled at the taxonomic level of the strain(s) used and at
the number of viable cells (Tumuola et al., 2001; Patrone
et al., 2016; Vecchione et al., 2018). Recently, various
attempts have been reported that aimed to deﬁne probi-
otic functions. Probiotic core beneﬁts have been
described that are shared among commonly used probi-
otic strains (Hill et al., 2014; Lebeer et al., 2018). Such
probiotic beneﬁts comprise operational functions, such
as colonization resistance, production of lactic and short-
chain fatty acids, regulation of intestinal transit, normal-
ization of perturbed microbiota, increased turnover of
enterocytes or competitive exclusion of pathogens. While
our fundamental knowledge of the underlying mecha-
nisms is still limited, an increasing number of these core
beneﬁts have been linked to speciﬁc molecules, struc-
tures or metabolic pathways that can be identiﬁed or pre-
dicted using molecular approaches.
Based on the above considerations, the question
arises how a probiotic product should be microbiologi-
cally characterized to establish its quality level. Taxo-
nomic considerations are usually based on sequence
analysis of 16S rRNA genes but increasingly include
genomic data. Microbial cell viability is currently veriﬁed
by standard plating procedure, and the data are
expressed as CFU per g of product. This is highly
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relevant since some studies have found that commercial
products did not contain the declared viable cell num-
bers (Ibrahim and Carr, 2006; Lin et al., 2006; Drago
et al., 2010; Morovic et al., 2016). However, other
aspects should be considered as well as to assess the
quality of a probiotic product and this should include the
amount and the relative abundance of damaged and
dead cells in the product. These data may be considered
as an indicator on how the microbial cells have been
prepared by the manufacturers. It should be stressed
that in some cases dead cells can maintain the probiotic
effects exerted by live cells, as reported in studies with
cell cultures, animals and human volunteers (Taverniti
and Guglielmetti, 2011; De Almada et al., 2016). Nowa-
days, several techniques based on differential cell stain-
ing are available for the quantiﬁcation of live and dead
microorganisms (Kramer et al., 2009; Davis, 2014;
Wilkinson, 2018). Moreover, in multi-strain probiotic prod-
ucts, besides the evaluation of the overall cell viability,
also the single species or strain viability should be con-
sidered. Several products on the market are blends of
different bacterial species, sometimes with the addition
of a yeast (Edwards-Ingram et al., 2007). In these multi-
species products, the relative abundance of viable cells
of each strain in the blend should be quantiﬁed as these
could have different shelf life and function. Considering
that the evaluation of the viability of different species in
a mixture by plate counting could be problematic
because of the absence of selective species-/strain-
speciﬁc media, the development of new approaches is
needed, such as those based on single-cell analysis
(Chiron et al., 2017). Moreover, genome-based molecu-
lar tools should be applied, such as metagenomics and
metaproteomics approaches, to address all DNA or pro-
teins in a sample as to contribute to a complete and
exhaustive microbiological characterization.
In this study, we used as a model the multi-strain pro-
biotic product VSL#3, consisting of eight strains belong-
ing to seven species that have previously been
characterized at the genome level (Douillard et al.,
2018). We developed a series of culture-independent,
metagenome and metaproteome-based microbiological
characterizations that could be applied for this and other
probiotic products to evaluate the species and strain
composition, viability and safety, as well as their proteins
and some enzymatic activities that could be used to
monitor the reproducibility of the biomass production pro-
cess. While some microbiological characterizations can
be routinely applied on all production lots of a commer-
cialized probiotic product (such as the quantiﬁcation of
live and dead cell by single-cell analysis, enzymatic
assays), other characterizations such as shotgun
metagenomics, or metaproteomics could be carried out
periodically when changes in the biomass production
process happened (e.g. change in media composition) in
order to evaluate the genomic stability of the strain/s
and/or the effect of the changes in media composition
on the overall proteome. Some of these approaches
could be used by producers, customers and regulators
to control the quality of probiotic products, as requested
recently (Kolace^k et al., 2017; Jackson et al., 2019).
Results and discussion
Identity, safety and composition of the VSL#3 product as
determined by metagenomics
The genomes of the individual VSL#3 strains have been
characterized previously (Douillard et al., 2018). To pro-
vide a genomic description of the multi-strain VSL#3 pro-
duct at the species and strain level, a commercial
sample (lot A) was characterized by deep shotgun
metagenomics since this would generate a level of taxo-
nomic depth that cannot be achieved by a standard phy-
logenetic analysis based on 16S rRNA gene proﬁling.
Because the relative abundance of each of the eight
strains blended in VSL#3 product is not known, a total of
5 Gb data were generated that included over 6 million
Illumina HiSeq reads. Using this sequence coverage, a
strain with a load of one billion of CFU up to an overall
load of 450 billions of CFU (declared in the product
label), and therefore representing approximately 0.22%
of the blend, should be theoretically covered by approxi-
mately 13 333 reads. The results obtained showed that
99.8% of the total reads matched with an identity of
> 99% to the genomes of the 8 strains that had been
previously described (Douillard et al., 2018). This con-
ﬁrmed the identity of the strains in this commercial
VSL#3 product. A minute number of 425 reads
(0.0068% of total reads) were found to have no match in
the VSL#3_custom_database and were considered as
contaminants originating from the production, laboratory
or sequencing processes.
Based on the ORFs count per genome, the relative
abundance of the individual VSL#3 strains was esti-
mated (Fig. 1). This does not necessarily reﬂect the real
VSL#3 formulation because the amount of dead cells in
the overall cell population could be different among the
bacterial strains blended in the product. Nevertheless,
the relative abundance estimated from metagenomic
data could be used as reference to compare different
production lots in terms of homogeneity of species com-
position. Based on metagenomic data, S. thermophilus
BT01 was the most abundant (63.4%) species in the
blend followed by B. animalis subsp. lactis (12.7% for
strain BI04 and 4.55% for strain BL03; see below),
L. paracasei BP07 (9.9%), L. acidophilus BA05 (7.2%),
L. plantarum BP06 (1.7%), L. helveticus BD08 (0.4%)
and B. breve BB02 (0.2%). A species-speciﬁc qPCR
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assay was carried out on total DNA extracted from lot A
and lot B, providing a high-throughput quantiﬁcation of
the VSL#3 species in the blend (Table 1). The qPCR
data conﬁrmed the metagenomic analysis with S. ther-
mophilus as the most abundant species in the blend fol-
lowed by B. animalis subsp. lactis and L. paracasei;
conversely, L. helveticus and B. breve showed the low-
est count. The qPCR data revealed a signiﬁcant higher
amount of L. paracasei in lot B as compared to lot A,
whereas the amounts of the other VSL#3 species in the
two lots analysed were comparable. Taking into consid-
eration that such multi-strain product was blended based
on viable cells quantiﬁed by plate count, the qPCR data,
which is biased by the unknown amounts of dead cells,
may not reﬂect the real formulation of the product. The
qPCR analysis targeting the pyk genes is not able to dis-
criminate between the two highly related B. animalis
subsp. lactis strains (Douillard et al., 2018). However,
the metagenomic analysis allowed their identiﬁcation
based on their SNP designation reported previously
(Barrangou et al., 2009; Milani et al., 2013), and the
SNP abundance was used to estimate their relative
abundance (Table 2). Taking into consideration the
closed pan-genome structure of this bacterial species,
the superimposable SNP proﬁle between VSL#3 B. ani-
malis subsp. lactis strains and the references strains
Bi07 and Bl04 (Milani et al., 2013) led us to hypothesize
an extremely high genomic identity between these
strains.
The deep metagenomics data also allowed for a fur-
ther characterization of B. animalis subsp. lactis BL03
and BI04. These strains differ in a 54 bp indel within the
gene Balac_0771 which codes for a long-chain acyl-CoA
synthetases involved in cell membrane lipid production.
We did not observe this small 54 bp indel in our previ-
ous genomic analysis because of variations in the
sequence coverage for the two B. animalis subsp. lactis
strains (Douillard et al., 2018). The 54-bp in-frame
Fig. 1. Metagenomics data (A) and relative abundance of VSL#3 strains (B) based on the ORFs count per VSL#3 genome from metagenomic
shotgun sequencing of total DNA extracted from VSL#3 lot A assigned by blast against VSL#3_custom_database. The relative abundance of
the VSL#3 species was estimated based on the ORFs count per VSL#3 genome. Taxonomy threshold > 95%.
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deletion leads to 18 amino acids shorter long-chain acyl-
CoA synthetases gene in strain BL03 as compared to
strain BI04. The 54-bp deletion was previously associ-
ated in B. animalis subsp. lactis strains to an increased
resistance towards oxidative stress (Oberg et al., 2011,
2013). Therefore, we could hypothesize that the VSL#3
B. animalis subsp. lactis BL03 and BI04 strains might
show differences towards oxidative stress, affecting their
cell viability in the blend, an aspect that needs to be fur-
ther investigated.
The metagenomic data were also used to address the
safety aspects of the studied VSL#3 product and con-
ﬁrmed what was previously reported by Douillard et al.
(2018). By using a cut-off of 80% identity, we detected
the tetW gene showing identities > 99% with tetW of
B. animalis subsp. lactis BL03 and BI04, and B. breve
BB02, together with the isoleucyl-tRNA synthetase cod-
ing for mupirocin resistance, an intrinsic antibiotic resis-
tance used to selectively cultivate Biﬁdobacteria (Rada
and Koc, 2000; ISO, 29981:2010; IDF 220:2010). The
tetW gene detected is present in well-characterized and
commercialized probiotics (Kleerebezem et al., 2003;
Garrigues et al., 2010) but has so far not found to be
transferable (Gueimonde et al., 2010). The tetW gene
was previously identiﬁed in VSL#3 strains BB02, BL03
and BI04, as was a potential aminoglycoside amino-
transferase coding gene in strain BI04 (Douillard et al.,
2018). Metagenomic data conﬁrmed the absence of
pathogenic islands or genes coding for toxic compounds,
thus conﬁrming previous data obtained from the genome
analysis of the individual VSL#3 strains (Douillard et al.,
2018).
Finally, the shotgun metagenomic data allowed to sup-
port a further characterization of the molecular basis of
the host interaction of VSL#3 strains. The predicted
potential probiotic features coded by VSL#3 metagen-
ome include several cell surface components of B. ani-
malis subsp. lactis, L. acidophilus, L. helveticus,
L. paracasei, L. plantarum and S. thermophilus, such as
pili, ﬁmbriae and ﬁbronectin proteins, and more generally
proteins containing the cell-wall anchoring LPXTG motifs
(Fig. 2). While the potential probiotic properties predicted
from the VSL#3 metagenome should be further validated
for each strain, these cell envelope proteins are known
to be involved in adhesion to the intestinal epithelium in
well-characterized probiotic strains, such as L. rhamno-
sus GG and B. breve UCC2003 (Kankainen et al., 2009;
O’Connell Motherway et al., 2011). Urease-encoding
sequences were only identiﬁed in S. thermophilus, thus
conﬁrming that this enzymatic activity is uniquely present
in this species among those constituting the VSL#3
product. A putative L. paracasei levanase coding
sequence was also identiﬁed, thus suggesting the poten-
tial ability of VSL#3 L. paracasei BP07 to hydrolyse inu-
lin, as recently demonstrated in for an L. plantarum
strain carrying this conserved gene (Buntin et al., 2017).
Evaluation of cell viability
According to the accepted probiotic deﬁnition (Hill et al.,
2014), the number of live bacterial cells in a probiotic
product represents a fundamental requirement. Never-
theless, the overall quality of the probiotic product should
also take into consideration the amount of damaged and
dead cells already present in the marketed product. The
publication of the ISO 19344 IDF 232 (2015) speciﬁed a
standardized method for the quantiﬁcation of active and/
or total lactic acid bacteria and probiotic strains in starter
cultures used in dairy products by means of ﬂow cytom-
etry. We therefore applied an optimized ﬂow cytometric
protocol to evaluate live, damaged and dead cells in two
commercial lots B and C of the multi-strain VSL#3 prod-
uct. The two VSL#3 lots showed a homogeneous distri-
bution of live, damaged and dead cells (respectively,
gated in G1, G2 and G3) independently of the expiration
Table 1. Quantiﬁcation of VSL#3 species by qPCR assay.
Species Lot B Lot C
Streptococcus
thermophilus
9.7 9 1010  8 9 109 1.6 9 1011  1 9 1010
Biﬁdobacterium
animalis
subsp. lactis
4.4 9 1010  4 9 109 4.3 9 1010  5 9 109
Lactobacillus
plantarum
6.8 9 109  3 9 108 6.5 9 109  4 9 108
Lactobacillus
acidophilus
4.2 9 109  2 9 108 6.3 9 109  5 9 108
Lactobacillus
paracasei
4.5 9 109  6 9 108 1.5 9 1010  4 9 109
Lactobacillus
helveticus
1.8 9 108  2 9 107 2.6 9 108  1 9 107
Biﬁdobacterium
breve
1.3 9 108  3 9 107 1.7 9 108  2 9 107
Table 2. Identiﬁcation and frequency of B. animalis subsp. lactis
strain-speciﬁc SNPs in the commercial VSL#3 product.
SNPa BI04 Bi07b BL03 Bl04b
Number
of. reads
6 (A) Yes Yes Yes Yes 88
8 (G) No No Yes Yes 17
8 (del) Yes Yes No No 43
44 (C) Yes Yes No No 37
44 (del) No No Yes Yes 12
BI04 73.6 %
BL03 26.4 %
a. SNP number designations are according to Milani et al. (2011).
b. B. animalis subsp. lactis reference strains (Milani et al., 2011).
Percentage of strain BI04 or BL03 = (number of reads speciﬁc for
strain BI04 or BL03 x 100)/(number of reads speciﬁc for strain
BI04 + number of reads speciﬁc for strain BL03).
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date of each lot number (Fig. 3). Live cells accounted for
approximately 3.8-3.9 1011 CFU g1, well above the
amount of live cell declared in the label (1.0
1011 CFU g1). Dead cells were between 8 and 10% of
the overall population in both lots, thus highlighting a
good optimization of the biomass production process. It
is worth to mention that while cells gated in G3 are con-
sidered dead, the fate of cells gated in G2, that is those
cells showing a moderate cell membrane damage and
therefore showing both SYTO24 and PI ﬂuorescence, is
not known. It is known that some of the viability of such
damaged cells may be rescued (Amor et al., 2002).
However, they also could completely lose their viability
and therefore they were not included in the count of
viable cells.
In situ analysis of enzymatic activities: b-galactosidase
and urease
Probiotics are living cells that can rapidly respond and
adapt to changing conditions in their environment. There-
fore, numerous factors including culture preparation and
preservation can affect probiotic cell activities (the core
beneﬁts) and probably inﬂuence the speciﬁc host–mi-
crobe interactions required for probiotic effects in the
digestive tract (Marco and Tachon, 2013; Sanders et al.,
2014). Hence, we have developed protocols for the mea-
surement of two enzymatic activities, b-galactosidase
and urease activity, which could be linked to changes in
the biomass production process parameters and media
composition. The selection of b-galactosidase activity
was based on the fact that 7 up to 8 VSL#3 strains con-
tain a b-galactosidase-encoding gene in their genomes.
It is known that in S. thermophilus, b-galactosidase gene
expression and activity is strictly linked to the energetic
status of the cells and the carbon source used in the
medium formulation, and it is therefore a good candidate
to monitor the reproducibility of the production process
(Van d Bogaard et al., 2000). As expected, a consider-
able amount of b-galactosidase activity was observed
(Table 3). The two lots analysed showed activity values
ranging between 8.8 and 9.3 AU, irrespective of the
expiration date of the analysed lot, thus indicating a high
stability of this enzymatic activity in the bacterial blend,
which was also conﬁrmed by the high cell viability.
Although urease activity has been associated with
several pathogens, the human gut microbiota urease
was more recently considered a health-related factor
associated with several bacteria colonizing the human
gastrointestinal tract (Mora and Arioli, 2014; Douillard
et al., 2018). Urease is supposed to act by modulating
the nitrogen availability of gut microbiota and host (Mill-
ward et al., 2000). This may be particularly the case
under conditions where dietary nitrogen is limiting (Yat-
sunenko et al., 2012). Moreover, urease activity is pre-
sent in well-characterized probiotics strains, such as
B. longum subsp. infantis, L. reuteri, S. salivarius (Power
et al., 2008; Lo Cascio et al., 2010; Wilson et al., 2014),
and in the yogurt bacteria S. thermophilus (Mora et al.,
2004). Since S. thermophilus is the dominant species in
the multi-strain probiotic product VSL#3 (see Table 1),
and the transcription of urease gene cluster is mainly
regulated by pH and nitrogen availability (Mora et al.,
2005; Arioli et al., 2007), urease activity was chosen as
a second marker to monitor the reproducibility of the
VSL#3 production process. Urease activity was mea-
sured as a shift of the cFSE ﬂuorescence of a cell
suspension exposed to urea (Fig. 4). The cFSE
Fig. 2. Probiotic functional classiﬁcation of the reads from metagenomic shotgun sequencing of total DNA extracted from VSL#3 lot A. Data
were assigned to general classes with the COG database. Data were expressed as relative abundance with respect to the total reads.
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ﬂuorescence is pH-dependent, and it increases during
the alkalization generated by urea hydrolysis and conse-
quent ammonia release. The developed assay allowed
to identify the urease-positive cell population within a
blend of urease-positive and urease-negative cells, and
to evaluate the urease activity as % of cFSE ﬂuores-
cence increase. The activity results shown here indicate
that the urease activity is clearly detectable in both com-
mercial lots of the VSL#3 blend (Fig. 4). In fact, a cyto-
metric population representing 52.1% of the total cFSE-
labelled cell community increased its ﬂuorescence due
to urea hydrolysis and a consequent intracellular alka-
lization (Fig. 4B). As a control, the addition of carbonyl
cyanide m-chlorophenyl hydrazine (CCCP), a membrane
uncoupling of the proton gradient which inactivate the
urea cell membrane transporter, and ﬂurofamide, a
urease inhibitor, inhibited the cFSE ﬂuorescence shift
(Fig. 4C and D). The results obtained showed that all
lots analysed showed comparable urease activity
(Fig. 4E). Since the urease activity was unique for
S. thermophilus (Douillard et al., 2018) as conﬁrmed
by the metagenomic analysis that also showed
S. thermophilus to have over 50 % abundance, we con-
clude that S. thermophilus in the VSL#3 blend is respon-
sible for the urease activity.
Interestingly, a small part from the main cytometric
population gated in P1, a small cytometric population
(gate P2 in Fig. 4) showing high level of cFSE ﬂuores-
cence, appeared to be affected by CCCP and ﬂuro-
famide treatment. These results clearly indicated that
S. thermophilus cells were present both in P1 and in P2
cytometric populations. The reasons of the special distri-
bution of S. thermophilus cells in the two cytometric pop-
ulations could be related to a population heterogeneity in
terms of chain length or to differences in intracellular
esterase activity which is responsible of cFSE activation.
Such heterogeneity in a homogenous genetic back-
ground is quite common in bacterial populations, and it
was previously reported for S. thermophilus and in Lac-
tococcus lactis among lactic acid bacteria (Arioli et al.,
2014; Solopova et al., 2014).
Metaproteomic characterization of VSL#3: Composition,
reproducibility and functionality
Metaproteomics approaches have been developed to
identify proteins in complex mixtures of microorganisms
(Klaassens et al., 2007; Kolmeder and de Vos, 2014).
Using advanced bioinformatics, the origins of the pro-
teins can be traced to the production organisms and this
has shown to be a useful way to identify the functions
of speciﬁc microorganisms (Kolmeder et al., 2015). As
a consequence, proteomics approaches can be
Fig. 3. A. Dot-plots of VSL#3 cell suspensions stained with SYTO24 and PI. Active ﬂuorescent cells (live cells) (Fc) were identiﬁed in the
green gate G1, damaged cells (Dc) were identiﬁed in blue gate G2, and non-active ﬂuorescent cells (dead cells) (nAFc) were identiﬁed in the
red gate G3. Lot B and lot C are indicated in the ﬁgure. B. Quantiﬁcation of Fc, Dc and nAFc. Statistically signiﬁcant differences were deter-
mined by an unpaired Student’s t test (P < 0.05). No signiﬁcant differences were detected for Fc (P: 0.7040) and Dc (P: 1.0000). Signiﬁcant dif-
ferences were detected for Dc (P: 0.0186).
Table 3. b-galactosidase activity of three VSL#3 lots.
Sample Expiration date b-galactosidase activity (AU)
Lot B 06/2018 8.8  0.3
Lot C 06/2019 9.3  0.3
AU, (mOD420nm min
1), statistically signiﬁcant differences were
determined by an unpaired Student’s t test (P < 0.05). No signiﬁcant
differences were detected, P: 0.1108.
ª 2019 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology., Microbial
Biotechnology, 12, 1371–1386
1376 D. Mora et al.
instrumental in characterizing the functionality of probi-
otic products and notably those derived from multiple
species. Moreover, it allows for compositional analysis
as well as determining reproducibility and temporal
development (Kolmeder et al., 2016). Hence, we applied
an earlier developed metaproteomic pipeline to two lots
B and C of the multi-strain product VSL#3, which
included triplicate analysis of the extracted proteins by
advanced LC-MS and identiﬁcation of the proteins by
using the genomic information of the VSL#3 product
(Douillard et al., 2018). The triplicate analysis showed
high protein intensity reproducibility with a Pearson cor-
relation coefﬁcient of on average 0.91. A total of 1659
proteins could be identiﬁed by at least 2 peptides in both
lots by using these LC-MS features. Of interest, these
proteins could be assigned to all 7 species present in
the VSL#3 product (see below). The correlation of the
LC-MS features between the two VSL#3 batches was
also high with a Pearson correlation coefﬁcient of on
average 0.81, and only 54 proteins (3.2 %) were found
to differ signiﬁcantly between the two lots as visualized
in the Volcano plot (Fig. 5). This indicates that both lots
have a very high similarity, notably when one takes into
account that the multi-strain products are manufactured
by mixing different amounts of freeze-dried cells of the
strains that make up the ﬁnal formulation. In normal
practice, this is realized by adjusting the number of cells
based on their viable plate count. However, in this way
the formulation contains both damaged and dead cells
(see above). The cell quantiﬁcation carried out by single-
cell analysis highlighted the presence of 3.7-4.4 x 1010
FU g1 of dead cells, the proteins of which contributing
to the metaproteome while not being enumerated by
plate counting.
Metabolic interpretation of the metaproteomic analysis
It can be seen from the Volcano plot that 25 proteins are
more abundantly present in lot B and 29 more in lot C
(Fig. 5). When comparing the proteome data sets of
Fig. 4. Dot-plots of VSL#3 cell suspensions stained with cFSE, before (A) and after the addition of 10 mM urea without (B) and with pretreat-
ment of cells with the membrane uncoupling CCCP (C), and with pretreatment of cells with the urease inhibitor ﬂurofamide (D). (E) Histogram
showing the urease-dependent shift in cFSE ﬂuorescence in VSL#3 lots B and C. The analytical imprecision of urease activity analysis based
on cFSE ﬂuorescence shift was < 20 %.
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these two commercial lots of VSL#3, two major effects
should be distinguished. One is simply that more cells of
a single strain have been added, for instance to com-
pensate for a slightly reduced viability, as is commonly
observed in industrial manufacturing practice. In this
case, the most abundant housekeeping proteins are
expected to be more prevalent. The alternative is that
cells of a speciﬁc strain were harvested a bit later or ear-
lier. This would result in the speciﬁc abundance of a set
of speciﬁc proteins that would respond to different
growth and medium conditions, stress or other factors.
When analysing the data of the two lots, no clear distinc-
tion could be made between these effects as only few
differentially present proteins were identiﬁed. The possi-
bility that both of these effects could occur simultane-
ously may also be considered but its analysis would
require very deep LC/MS analysis that is beyond the
present proof of principle study. Below, the differently
abundant proteins in both batches are discussed in
some detail.
Apart from a 50S ribosomal protein from B. animalis
subsp. lactis, a fumarate hydratase of L. plantarum and
a OppA of L. helveticus, all other of the 22 proteins that
were found to be more abundant in lot B were found to
derive from L. paracasei. The L. paracasei proteins
included components of sugar, amino acid and nucleo-
tide metabolism, such as glucoside PTS, oligopeptide
and other transport systems, alpha-galactosidase, dipep-
tidyl peptidase, and cysteine synthase. Taking into con-
sideration the formulation of VSL#3 product, this may
suggest that relative to lot C, slightly more L. paracasei
cells were included in lot B. This is indeed the case as
was concluded from the qPCR-based quantiﬁcation of
VSL#3 species that showed a higher level of L. paraca-
sei in lot B than lot A (see Table 1). A possible explana-
tion could be that this was due to a slightly reduced
viability of L. paracasei cells in lot B that was compen-
sated by blending in more cells of this species. Riboso-
mal proteins are usually highly abundant, and hence, it
is possible that the presence of B. animalis subsp. lactis
50S ribosomal protein was indicative of slightly higher
amounts of cells of this species were included in lot B
as compared to lot C. However, this was not conﬁrmed
by the qPCR-based quantiﬁcation (Table 1).
When analysing the proteins that were found to be
more abundant in lot C than lot B, considerable
Fig. 5. Volcano plot of the protein species (red P-value above 0.05) that differ signiﬁcantly in abundance between lot B (left) and lot C (right).
The signiﬁcant P-value of 0.1 is indicated by the solid line. Contaminants are indicated by green dots. A listing of the differentially abundant pro-
tein species is provided in Table S2.
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heterogeneity in the origin of the proteins was observed
since they derive from L. plantarum, L. helveticus, L. aci-
dophilus, S. thermophilus and B. animalis subsp. lactis.
A slightly higher abundance of S. thermophilus, L. hel-
veticus and L. acidophilus in lot C compared to lot B
was also conﬁrmed by the qPCR-based quantiﬁcation
data (Table 1), whereas qPCR was not able to support
differences in cell count between the two lots for L. plan-
tarum and B. animalis subsp. lactis. The distinct proteins
from L. plantarum included mainly glycolytic enzymes,
such as a phosphoglycerate mutase, glucose 6-phos-
phate isomerase and fructose-bisphosphate aldolase,
suggesting again that cells of this strain may have been
faster growing in lot C than lot B. Only a single protein
from L. helveticus (hypothetical protein CDA64_01223)
was most abundant in lot C and showed high similarity
with a cell division or separation protein but has no con-
ﬁrmed function. A similar situation could apply to L. aci-
dophilus, from which a single enzyme UDP- N-
acetylmuramoylalanine-D-glutamate ligase potentially
involved in peptidoglycan biosynthesis was somewhat
more abundant in lot C as compared to lot B.
Most of the distinct proteins in lot C derived from S. ther-
mophilus and included a signal peptidase, some trans-
porters and components involved in central and energy
metabolism. Of interest is the higher abundance in the
S. thermophilus cells in lot C of a hemin transporter HmeB,
which is part of an ABC transporter. While hemin can be
incorporated in cytochromes produced by various lactic acid
bacteria, this property is not known for dairy strains of
S. thermophilus. Hence, the abundance of HmeB and other
distinct S. thermophilus proteins may reﬂect a general
response to the culture medium conditions. The abundant
proteins derived from B. animalis subsp. lactis were pre-
dicted to have a variety of metabolic functions and the most
abundantly produced proteins included GrpE and GalE. The
latter proteins are involved in heat-shock and other stress
response (GrpE) (a heat-shock and general stress response
protein) and GalE (UDP-glucose 4 epimerase involved in
exopolysaccharide (EPS) formation); the speciﬁc abundance
of these proteins may be interpreted as to indicate that the
cells of B. animalis subsp. lactis in lot C were slightly more
stressed than in lot B. According to the supposed differences
in susceptibility to oxidative stress between strain BI04 and
BL03 due to the allelic variants of the long-chain acyl-CoA
synthetases gene (Oberg et al., 2011, 2013), it could be also
hypothesized that cells of strain BI04 were slightly more
abundant in lot B than those of strain BL03.
Metaproteome-based functionality analysis of the VSL#3
products
As indicated above, the two investigated lots of VSL#3
are highly similar in composition and it is virtually
impossible to attribute differences to different cell num-
bers or different growth and processing conditions of the
species used to produce VSL#3. One way to approach
this is to consider housekeeping proteins as a proxy for
the cell numbers of the different species, although this
would not account for potential differences in cell mor-
phology. A number of such housekeeping proteins have
been selected because of their high level of expression,
and they can be easily assigned to each VSL#3 species
based on their amino acid sequence. They include gly-
colytic enzymes such as enolase, pyruvate kinase and
GAPDH, but also b-galactosidase and S-layer proteins
due to their high abundance (Table 4). In this context,
the proteomic data were consistent with the measured b-
galactosidase (Table 3) that were not signiﬁcantly differ-
ent between the two lots, analogously to what reported
by the metaproteomic data for S. thermophilus, B. ani-
malis subsp. lactis and L. helveticus b-galactosidase
(Table S2).
The S-layer proteins are highly relevant because these
are known to be involved in adhesion to intestinal epithe-
lial cells and extracellular matrix components (Buck
et al., 2005). Adhesion is believed to be a requirement
for the achievement of certain probiotic effects, such as
immunomodulation. More recently, the S-layer of L. aci-
dophilus and L. helveticus showed to possess an impor-
tant immunomodulatory activity. Speciﬁcally, SlpA of
L. acidophilus was found to interact with a major recep-
tor on dendritic cells and regulates dendritic cell immune
functions (Konstantinov et al., 2008), whereas SlpA of
L. helveticus showed anti-inﬂammatory effects by reduc-
ing the activation of NF-kB on the intestinal epithelial
Caco-2 cell line and acts as stimulators of the innate
immune system by triggering the expression of proin-
ﬂammatory factors tumour necrosis factor alpha and
COX-2 in the human macrophage cell line U937 via
recognition through Toll-like receptor 2 (Taverniti et al.,
2013). Based on the above consideration, S-layer pro-
teins of L. acidophilus and L. helveticus should be con-
sidered a probiotic core beneﬁt involved in host
adhesion and interaction. Hence, the observation that in
both lots of the VSL#3 the S-layer proteins of L. aci-
dophilus and L. helveticus are abundant and comprise a
similar level testiﬁes for the reproducibility of their probi-
otic functions. This is of great relevance since the thera-
peutic dose of VSL#3 is relatively high (450–900 billion
cells per day) and the product may be active without fur-
ther multiplication after consumption.
With the exception of the S-layer proteins whose
expression is known to be high and constitutive (Klotz
and Barrangou 2018), the expression of b-galactosidase
and glycolytic enzymes could be affected by changing in
the production process parameters and/or media formu-
lation as it was demonstrated for S. thermophilus and
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Lactococcus lactis (Van den ogaard et al., 2000; Teusink
et al., 2011).
Conclusions
The multi-strain VSL#3 product is a high dosage probi-
otic blend consisting of 8 different strains belonging to 7
Lactobacillus, Biﬁdobacterium and Streptococcus spp.
This complex product represents an excellent model to
develop an appropriate set of omics-based culture-inde-
pendent protocols to evaluate its microbiological quality.
The compositional complexity of VSL#3 was ﬁrst
addressed through a metagenomic approach that
allowed a detailed taxonomic and functional characteri-
zation of the product, giving also information on the rela-
tive abundance of the strains constituting the blend and
on their safety. The metagenomic results generated
here, together with the previous characterization of
VSL#3 strains at genomic level (Douillard et al., 2018),
provide the basis for controlling the genetic stability of
the product along the industrial productions. It is well
known that genetic changes due to mutations,
repositioning of mobile elements such as plasmids, pro-
phages and insertion sequences/transposons, as well as
the immunity-based CRISPR sequences, may occur in
Lactobacillus, Biﬁdobacterium and Streptococcus spp.
(Sanders et al., 2014; Lugli et al., 2019). Two indepen-
dent lots of VSL#3 were subjected to ﬂow cytometric,
biochemical and metaproteomic analysis. The live/dead
cell counts conﬁrmed that the analysed lots contained
the amounts of live cells declared on the product label.
In addition, we measured in the sachets of the two lots
the level of b-galactosidase and urease activity to moni-
tor the reproducibility of the production process. Simi-
larly, the metaproteomic approach showed that both lots
contained relatively high levels of the S-layer proteins of
L. acidophilus and L. helveticus, another set of potential
probiotic beneﬁts. Finally, the detailed metaproteomic
characterization of the two different lots revealed only a
minor number of proteins to be differentially
expressed (54 from the 1659 detected), supporting a
high standardization level of the fermentation processes
applied for the production of the 8 different VSL#3
strains.
Table 4. Size-corrected relative abundance of selected housekeeping proteins as analysed in triplicate in the VSL#3 products lot B and lot C
Description
VSL3 lot Ba VSL3 lot Ca
B1 B2 B3 C1 C2 C3
POO10663.1 S-layer protein [Lactobacillus acidophilus] 9.50 9.44 9.52 9.65 9.73 9.69
POO10880.1 Glyceraldehyde-3-phosphate dehydrogenase [Streptococcus thermophilus] 9.37 9.35 9.31 9.55 9.50 9.59
POO15824.1 Enolase [Streptococcus thermophilus] 9.35 9.32 9.39 9.54 9.60 9.56
POO12483.1 Pyruvate kinase [Streptococcus thermophilus] 9.20 9.18 9.25 9.34 9.41 9.41
POO18406.1 Glyceraldehyde-3-phosphate dehydrogenase [Lactobacillus paracasei] 9.40 9.33 9.34 9.23 9.19 9.28
POO19292.1 Pyruvate kinase [Lactobacillus paracasei] 9.42 9.45 9.49 9.13 9.23 9.24
POO14182.1 Beta-galactosidase [Streptococcus thermophilus] 8.90 8.84 8.98 9.06 9.00 8.87
POO09985.1 Glyceraldehyde-3-phosphate dehydrogenase [Lactobacillus acidophilus] 8.88 8.89 8.87 8.99 8.93 8.94
POO11362.1 Pyruvate kinase [Lactobacillus acidophilus] 8.82 8.85 8.85 8.92 9.00 8.97
POO18403.1 Enolase [Lactobacillus paracasei] 9.14 9.11 9.13 8.85 8.88 8.97
POO11424.1 Enolase [Lactobacillus acidophilus] 8.65 8.62 8.65 8.67 8.72 8.69
POO06052.1 Enolase [Biﬁdobacterium animalis subsp. lactis] 8.26 8.29 8.31 8.63 8.72 8.72
POO05890.1 Glyceraldehyde-3-phosphate dehydrogenase [Biﬁdobacterium animalis
subsp. lactis]
8.24 8.17 8.28 8.59 8.58 8.46
POO31756.1 S-layer protein [Lactobacillus helveticus] 8.20 8.26 8.26 8.44 8.48 8.44
POO10183.1 S-layer protein [Lactobacillus acidophilus] 7.78 7.73 7.70 8.30 8.22 8.29
POO10711.1 S-layer protein [Lactobacillus acidophilus] 7.57 7.67 7.70 8.25 8.22 8.15
POO13015.1 Glyceraldehyde-3-phosphate dehydrogenase [Lactobacillus plantarum] 7.10 7.32 7.11 8.24 8.19 8.18
POO31797.1 Glyceraldehyde-3-phosphate dehydrogenase [Lactobacillus helveticus] 7.47 7.51 7.50 7.99 7.88 7.92
POO06020.1 Pyruvate kinase [Biﬁdobacterium animalis subsp. lactis] 7.54 7.56 7.53 7.75 7.77 7.67
POO14527.1 Pyruvate kinase [Lactobacillus plantarum] 6.36 6.42 6.75 7.75 7.80 7.75
POO31994.1 Pyruvate kinase [Lactobacillus helveticus] 7.36 7.35 7.41 7.61 7.70 7.46
POO13018.1 Enolase 1 [Lactobacillus plantarum] 6.72 6.62 6.56 7.47 7.54 7.56
POO30743.1 Enolase [Lactobacillus helveticus] 6.69 7.19 7.25 7.24 6.83 7.44
POO08557.1 Glyceraldehyde-3-phosphate dehydrogenase [Biﬁdobacterium breve] 6.57 6.43 6.53 6.52 6.37 6.42
POO07455.1 Beta-galactosidase [Biﬁdobacterium animalis subsp. lactis] 5.70 5.91 5.93 4.30 6.07 6.00
POO30985.1 S-layer protein [Lactobacillus helveticus] 4.30 4.30 4.30 4.30 4.30 4.30
POO31036.1 S-layer protein [Lactobacillus helveticus] 4.30 4.30 4.30 4.30 4.30 4.30
POO31431.1 Beta-galactosidase small subunit [Lactobacillus helveticus] 4.30 4.30 4.30 4.30 4.30 4.30
POO31432.1 Beta-galactosidase large subunit [Lactobacillus helveticus] 4.30 4.30 4.30 4.30 4.30 4.30
a. B1, B2 and B3 represent the protein relative abundance of each replicate of lot B; C1, C2 and C3 represent the protein relative abundance
of each replicate of lot C.
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There are presently no accepted guidelines to control
the quality of the commercialized probiotic products in
spite of the demand for these (Kolace^k et al., 2017; Jack-
son et al., 2019). Previous studies have revealed the
potential of omics-based technology to address the micro-
bial composition at species and strain level in order to ver-
ify the correctness of the product label (Morovic et al.,
2016; Lugli et al., 2019). Without attempting to set new
standards, we here evaluated the potential of high-
throughput and omics-based approaches to contribute to
the required microbiological quality control. We addressed
the following microbiological quality criteria that we pro-
pose to be useful for future considerations. (i) Taxonomy.
Correct taxonomy of the strains according to the latest
state of the art technology and supported by genomic or
metagenomic characterizations. (ii) Viability. Several tech-
niques based on differential cell staining are available for
the quantiﬁcation of live and dead microorganisms and
should therefore be applied. Single-cell analysis carried
out by ﬂow cytometry is a useful and robust approach.
However, it may be difﬁcult to quantify mixed microbial
constituents in routine industrial and commercial product
quality assessments. Moreover, in multi-strain products,
different species/strains could have a different shelf life in
the blend. In this context, ﬂow cytometric methods com-
bining speciﬁc antibodies and viability assessment with
SYTOTM24 (Chiron et al., 2017) together with the Flow-
Fish approach based on ﬂuorescent probes targeted to
the 16S rDNA (Rigottier-Gois et al., 2003) could be suit-
able approaches. (iii) Safety. Probiotic strains should sat-
isfy the safety issues in terms of antibiotic resistances
according to EFSA and other recommendations. While
these quality criteria could be easily measured in single-
strain product, the MIC evaluation in multi-strain product
could be extremely complex, and metagenomic
approaches may have an advantage. (iv) Reproducibility
of biomass production. Variation in the production process
parameters can affect the level of some enzymatic activi-
ties associated with one or several strains blended in the
probiotic products. Some of these enzymatic activities
could be used as a marker to monitor the overall repro-
ducibility of the fermentation processes, and here, we
showed the feasibility of using b-galactosidase and
urease for that purpose.
In conclusion, we have shown the feasibility of apply-
ing a series of microbiological quality criteria to the multi-
strain product VSL#3. While it is too early to set an
industrial standard, we propose that for human interven-
tion trials the used probiotic lots are characterized by
these microbiological quality control criteria. This will pro-
vide a better comparison between different studies, allow
retrospective explanations in case of deviating clinical or
health outcomes and contribute to further assessing the
role of probiotics in human health.
Experimental procedure
The VSL#3 products tested
Different lots of the commercially available VSL#3 pro-
duct were characterized, and all were obtained from
Actial Farmaceutica SRL, Italy. All VSL#3 lots were pro-
duced by Nutrilinea Srl and commercialized as sachets
containing freeze-dried bacterial cells to be stored at
4°C. These were shipped to the different laboratories on
ice and stored at 4°C as indicated in the product speciﬁ-
cations. All tests were performed within the time set by
the expiry date.
Shotgun metagenomic analysis
Ten grams of a commercial sample of VSL#3 (lot A) was
suspended to a ﬁnal volume of 10 ml of TE buffer (1M
Tris-HCl pH 8.0, 0.1M EDTA). 400 µl of a sample dilution
corresponding to approximately 109 cells was collected.
The cell suspension was subjected to alkaline lysis and
DNA extraction according to the protocol described previ-
ously (Mora et al., 2004). DNA quantiﬁcation and quality
evaluations were performed with a Qubit ﬂuorometric quan-
tiﬁcation (Thermo Fisher Scientiﬁc, Milan, Italy). The quanti-
ﬁed DNA was delivered to BaseClear (Leiden, the
Netherlands) for shotgun metagenomic Illumina Nextera
XT library preparation and sequencing on Illumina HiSeq
2500 (guaranteed 5Gb HiSeq 2500 paired-end data per
sample). For bioinformatic analysis, paired-end reads have
been merged with FLASH (Fast Length Adjustment of
SHort reads) tool (Magoc and Salzberg, 2011) and then
assembled into contigs with MEGAHIT tool (Li et al., 2015)
using standard parameters. ORF prediction was subse-
quently performed with Prodigal Gene Prediction Software
with –p meta parameter (optimization for metagenomic
data). Blast search analysis was performed using
BLAST + suite from NCBI. Nucleotide sequences were ini-
tially aligned against ‘nt’ database from NCBI consisting of
nucleotide sequences from GenBank, EMBL and DDBJ,
excluding bulk divisions (gss, sts, pat, est, htg) and wgs
entries. A second database (VSL#3_custom_-
database_nucl) was used to conﬁrm the previous results.
VSL#3_custom_database_nucl was built using annotated
contigs from the eight bacterial strains present in VSL#3
product (accession number PRJNA388854) (Douillard
et al., 2018). Amino acid sequences were initially aligned
against ‘nr’ database from NCBI composed by non-redun-
dant protein sequences from GenPept, SwissProt, PIR,
PDF, PDB and NCBI RefSeq (ftp://ftp.ncbi.nlm.nih.gov/bla
st/db/). A second database (VSL#3_custom_-
database_prot) was used to conﬁrm the previous results.
VSL#3_custom_database_prot was built using annotated
proteins from the 8 bacterial strains present in VSL#3
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product (accession number PRJNA388854). Both BLASTn
and BLASTp analysis were performed with a threshold of
10-5 on the E-value, and only results that showed a
nucleotide identity> 98% and an amino acid identity higher
than 90% were used for further analysis. Functional classi-
ﬁcation was assigned performing a blast analysis against
Clusters of Orthologous Groups (COG) database from
NCBI. ORFs associated with genes known to code for pro-
teins that could be associated with probiotic effects were
detected using keyword searches against previous results
from blast against nr and VSL#3_custom_database_prot.
A list of proteins and genes of interest was reported previ-
ously (Douillard et al., 2018). To identify reads associated
with antibiotic resistant genes (ARGs), the data were com-
pared with the CARD (Comprehensive Antibiotic Resis-
tance Database) (McArthur et al., 2013). BLASTp analysis
was performed in order to identify the antibiotic resistance-
encoding reads with a threshold of 10-5 on the E-value.
Only sequences with an amino acid identity> 80% were
considered. Due to the extremely high level of identity
between the two Biﬁdobacterium animalis subsp. lactis pre-
sent in the mixture (Douillard et al., 2018), differentiation of
the two strains has been performed through a SNP analy-
sis based on data reported previously (Milani et al., 2013).
The metagenomic sequences were deposited in NCBI’s
Sequence Read Archive (SRA) with the following acces-
sion number PRJEB31428. The relative abundance of the
VSL#3 species was estimated based on the ORFs count
per VSL#3 genome. Reads that did not match against
VSL#3_custom_database were processed using Geneious
Prime software. Reads with length smaller than 80 bp
were discarded. MegaBlast analysis was performed
against NCBI nt_db (E-value 10^-5). Duplicates were
removed, and only sequences with grade score > 90%
were considered and used for the analysis (grade score is
a weighted score for the hit comprised of the E-value).
Quantiﬁcation of VSL#3 species by species-speciﬁc
qPCR
Quantiﬁcation of product species was carried out by qPCR
using primer sets targeted to the single-copy gene pyk
coding for pyruvate kinase (Table S1). The qPCR analysis
was performed using 5 ng of DNA extracted as above
described in a total volume of 15 ll, by using the Eva-
GreenTM kit (Bio-Rad Laboratories, Milano, Italy) and fol-
lowing manufacturer’s recommendations. PCRs were
performed in triplicate and run on a CFX96 instrument
(Bio-Rad Laboratories). Data were recorded as threshold
cycles (Ct), expressed as the mean  standard deviations,
and analysed using Bio-Rad CFX ManagerTM software. A
calibration curve for each VSL#3 species that reported the
Ct vs. number of cells was obtained. For this purpose,
VSL#3 strains obtained by Actial Farmaceutica Srl were
grown as previously described (Douillard et al., 2018). After
growth, cells were collected by centrifugation, suspended
in BPW buffer (casein peptone 10 g l1, NaCl 5 g l1,
Na2HPO4 3.5 g l
1, KH2PO4 1.5 g l
1, pH 7.0) and quanti-
ﬁed by ﬂow cytometry (FU ml1) as described below. Cells
diluted in BPW buffer were subjected to total DNA extrac-
tion using DNeasy UltraClean Microbial Kit (Qiagen, Hil-
den, Germany) according to the manufacturer’s
speciﬁcations. Five microlitres of DNA was used as a tem-
plate in qPCR assays with the appropriate species-speciﬁc
primer set (calibration curves obtained for each species
are shown in Fig. S1).
Counting viable, damaged and dead cell by single-cell
analysis
Cell counting was performed on two commercial lots
(lots B and C) of the multi-strain product VSL#3 by ﬂow
cytometry using an Accuri C6 ﬂow cytometer (BD Bio-
sciences, Milan, Italy) (Sincock and Robinson, 2001;
Gunasekera et al., 2003). A total of 10 g of each lot was
suspended in up to 100 ml of BPW buffer and homoge-
nized in a stomacher for 3 min at room temperature. The
obtained cell suspensions were analysed by ﬂow
cytometer (threshold settings FSC 5000, and 50 ll) with-
out and with labelling with SYTOTM24 and propidium
iodide (PI) (Thermo Fisher Scientiﬁc). All of the parame-
ters were collected as logarithmic signals. The 488 nm
laser was used to measure the FSC values. The rate of
events in the ﬂow was generally lower than 2,000
events s1. The staining principle is based on a dual
nucleic acid staining with cell-permeant dye SYTOTM24,
and cell-impermeant dye PI. SYTOTM24 permeates the
membrane of total cells and stains the nucleic acids with
green ﬂuorescence. PI penetrates only bacteria with
damaged membranes, causing a reduction in SYTOTM24
ﬂuorescence when both dyes are present. Thus, live
bacteria with intact cell membranes ﬂuoresce bright
green (deﬁned as active ﬂuorescent cells), bacteria with
slightly damaged membranes exhibit both green and red
ﬂuorescence (deﬁned as damaged cells), whereas bac-
teria with broken membranes ﬂuoresce red (deﬁned as
non-active ﬂuorescent cells). The ﬂow cytometric abso-
lute count was performed using the FluoresbriteTM poly-
chromatic red 2.0 lm microspheres as reference
(Polysciences Europe GmbH, Hirschberg an der Berg-
strasse, Germany). The SYTO24 ﬂuorescence intensity
of stained cells was recovered in the FL1 channel (exci-
tation, 488 nm; emission ﬁlter, 530/30), whereas PI ﬂuo-
rescence was recovered in the FL3 (excitation, 488 nm;
emission ﬁlter, 610/20). Density plots of SYTO24 vs. PI
allowed for optimal distinction between the SYTO24-PI
stained cells and instrument noise or sample back-
ground. Electronic gates on the SYTO24/PI density plot
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were used to select and measure the total bacterial con-
centration (events per ml), active ﬂuorescent cells (AFc),
damaged cells (Dc) and non-active ﬂuorescent cells
(nAFc) as described in ISO 19344 IDF 232.
Flow cytometry-based measurement of urease activity
Urease activity measurement was carried out in cell sus-
pensions of each lot B and C prepared in as described
above but using Mitsuoka buffer instead of BPW (Muto
et al., 2010). Cells were stained using the pH-sensitive
ﬂuorescence probe 5 (and 6-)-carboxyﬂuorescein succin-
imidyl ester (cFSE), based on the method originally
described by Breeuwer et al. (1996), later improved
slightly (Sawatari and Yokota, 2007), and modiﬁed as
described in Arioli et al. (2017). The ﬂuorescence inten-
sity of this probe increases at alkaline pH and decreases
at acidic pH. Cell suspensions in Mitsuoka buffer were
obtained as described above, diluted to obtain approxi-
mately 1000–2000 events ll1 and supplemented with
4 µM cFDASE (Sigma-Aldrich, Milan, Italy), which is a
precursor molecule of cFSE. The suspensions were then
incubated for 30 min at 37°C. During this incubation, the
membrane-permeating cFDASE was cleaved by intracel-
lular esterases and the resultant cFSE molecules were
conjugated to the aliphatic amines of intracellular pro-
teins. Apart from pH, the intensity of the ﬂuorescence
depends on the esterase activity of the cells and could
be a species- and/or strain-dependent feature. After the
measurement of cFSE ﬂuorescence, the Mitsuoka cell
suspension was supplemented with urea 10 mM and
incubated at 37°C. cFSE ﬂuorescence was measured
every 5-min interval for 15–30 min. Urease activity was
expressed as the % increase of the average cFSE ﬂuo-
rescence of the cytometric population as follows: [(cFSE
ﬂuorescence after urea addition – cFSE ﬂuorescence before
urea addition)/cFSE ﬂuorescence before urea addition]x100.
b-galactosidase activity
Samples of each lot B and C were suspended (1 g in
10 ml) in sterile 50 mM Tris-HCl buffer (pH 8.0) and
quantiﬁed by ﬂow cytometry. The cell suspensions
(108 CFU ml1) were permeabilized as described by
Krishnan et al. (2000) with the following modiﬁcation.
First, the cell suspension was supplemented with an
equal volume of 10% (v/v in water) toluene. Subse-
quently, the obtained suspension was incubated for
2 min at 30°C with shaking (100 rpm, Unimax 2010, Hei-
dolph Instruments, Milano, Italy). Finally, the permeabi-
lized cells were recovered by centrifugation (12,000 x g,
5 min), washed twice in Tris-HCl buffer (pH 8.0) and
used immediately for b-galactosidase assay. Measure-
ment of the b-galactosidase activity was performed in
200 ll aliquots of permeabilized cell suspension contain-
ing 0.2 mg ml1 of 2-nitrophenyl-b-D-galactopyranoside
(Sigma-Aldrich, Milano, Italy) at 37°C, by monitoring the
optical density at 420 nm with a microplate-reader M680
(Bio-Rad Laboratories, Hercules, CA, USA) programmed
for a reading set of 60 repetitions with intervals of 30 s.
The b-galactosidase activity was expressed in arbitrary
units (AU) deﬁned as mO.D.420 nm per min as the mean
of four independent determinations.
Metaproteomic analysis
The two different commercial lots B and C of the VSL#3
product were also analysed by metaproteomics. For each
analysis, 0.5 g of the product was suspended in 1 ml lysis
buffer (4% SDS, 50 mM DTT in 100 mM Tris.HCl, pH 7.6)
and transferred to an autoclaved 2.0-ml screw-cap tube,
containing 0.5 g 0.1 mm zirconia/silica beads and ﬁve
2.5 mm glass beads. The suspensions were bead-beaten
at room temperature for three cycles of 60 s with a 5-s
ramp-up time, at 5500 ms using a Precellys 24 bead-beat-
ing machine. The samples were cooled on ice after every
cycle. The suspension was then spun down for 5 min at
21 130 g, 4°C, and the supernatant was transferred to a
clean 2.0-ml Eppendorf tube, quantiﬁed by Bradford analy-
sis, and stored at 20°C. Subsequently, aliquots contain-
ing 40 µg of protein were prepared in triplicate for
denaturing polyacrylamide gel electrophoresis on a pre-
cast Invitrogen Bolt 4–12% Bis-Tris Plus gel after heating
for 5 min at 95°C. Protein separation, excision of gel slices
(four per loaded sample), reduction and alkylation, tryptic
digestion and analysis by nLC (Proxeon EASY) connected
to a LTQ-Orbitrap XL (Thermo Electron) were performed
as described previously (Oosterkamp et al., 2013; Buntin
et al., 2017). Spectra were analysed using MaxQuant
1.5.2.8 and a database of common contaminants, next to
protein databases of the reported genomes of the VSL#3
strains, which were used as input (Douillard et al., 2018,
16.468 sequences) and those of Escherichia coli K12 and
BL21-DE3 as possible contaminants. The ‘Speciﬁc Tryp-
sin/P’ digestion mode was used in MaxQuant as described
previously (Cox et al., 2011) with maximally 2 missed
cleavages and further default settings for the Andromeda
search engine (including ﬁrst search 20 ppm peptide toler-
ance, main search 4.5 ppm tolerance, IT-MS-MS fragment
match tolerance of 0.5 Da, carbamidomethyl (C) set as a
ﬁxed modiﬁcation, while variable modiﬁcations were set for
protein N-terminal acetylation and M oxidation, which were
completed by non-default settings for de-amidation of N
and Q; the maximum number of modiﬁcations per peptide
was 5). The ‘label-free quantiﬁcation’ and the ‘match
between runs’ options were enabled. De-amidated pep-
tides were allowed to be used for protein quantiﬁcation,
and all other quantiﬁcation settings were kept default.
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Filtering and further bioinformatic analysis of the Max-
Quant/Andromeda workﬂow output and the analysis of the
abundances of the identiﬁed proteins were performed with
the Perseus 1.5.5.3 module (Tyanova et al., 2016).
Accepted were peptides and proteins with a false discov-
ery rate (FDR) of < 1% and proteins with at least two iden-
tiﬁed peptides of which at least one should be unique and
at least one should be unmodiﬁed. Reversed hits were
deleted from the MaxQuant result table. The normal loga-
rithm was taken from protein LFQ MS1 intensities as
obtained from MaxQuant. Zero ‘Log LFQ’ values were
replaced by a value of 4.3 (a value slightly lower than the
lowest measured value) to make sensible ratio calculations
possible. Relative protein quantitation of the two sample
lots was done with Perseus by applying a two-sample t
test using the ‘LFQ intensity’ columns. Protein groups that
were found to deviate by more than a factor of 10 (log
abundance < 1 or > 1) and a P-value smaller than 0.01
(log P-value > 2) were considered to be signiﬁcantly dif-
ferent. The nLC-MSMS system quality was checked with
PTXQC using the MaxQuant result ﬁles, as described pre-
viously (Bielow et al., 2016).
Acknowledgements
All bioinformatic analyses were performed using the facil-
ities of CINECA SCAI (SuperComputing Applications
and Innovation) (CINECA, Bologna, Italy). We are grate-
ful to Julian Ket for his technical support in the pro-
teomics experiments. This study was partly funded by
Actial Farmaceutica SRL, who also provided the com-
mercial VSL#3 products, and the Netherlands Organiza-
tion for Scientiﬁc Research (Spinoza Award 2008 and
SIAM Gravitation Grant). Actial Farmaceutica SRL, like
the other funders, had no role in study design, data col-
lection and analysis, decision to publish, or preparation
of the manuscript.
Conﬂict of interest
DM and WMdV are in the Scientiﬁc Advisory Board of
Actial Farmaceutica SRL.
References
Amor, K.B., Breeuwer, P., Verbaarschot, P., Rombouts,
F.M., Akkermans, A.D., De Vos, W.M., et al. (2002) Multi-
parametric ﬂow cytometry and cell sorting for the assess-
ment of viable, injured, and dead biﬁdobacterium cells
during bile salt stress. Appl Environ Microbiol 68: 5209–
5216.
Arioli, S., Monnet, C., Guglielmetti, S., Parini, C., De Noni,
I., Hogenboom, J., et al. (2007) Aspartate biosynthesis is
essential for the growth of Streptococcus thermophilus in
milk, and aspartate availability modulates the level of
urease activity. Appl Environm Microbiol 73: 5789–5796.
Arioli, S., Guglielmetti, S., Amalﬁtano, S., Viti, C., Marchi,
E., Decorosi, F., et al. (2014) Characterization of tetA-like
gene encoding for a major facilitator superfamily efﬂux
pump in Streptococcus thermophilus. FEMS Microbiol Let-
ters 355: 61–70.
Arioli, S., Della Scala, G., Remagni, M.C., Suknyte, M.,
Colombo, S., Guglielmetti, S., et al. (2017) Streptococcus
thermophilus urease activity boosts Lactobacillus del-
brueckii subsp. bulgaricus homolactic fermentation. Int J
Food Microbiol 247: 55–64.
Barrangou, R., Briczinski, E.P., Traeger, L.L., Loquasto,
J.R., Richards, M., Horvath, P., et al. (2009) Comparison
of the complete genome sequences of Biﬁdobacterium
animalis subsp. lactis DSM 10140 and Bl-04. Appl Envi-
ron Microbiol 191: 4144–4151.
Bielow, C., Mastrobuoni, G., and Kempa, S. (2016) Pro-
teomics quality control: quality control software for Max-
Quant results. J Proteome Res 15: 777–787.
Breeuwer, P., Drocourt, J.L., Rombouts, F.M., and Abee, T.
(1996) A novel method for continuous determination of
the intracellular pH in bacteria with the internally conju-
gated ﬂuorescent probe 5 (and 6-)-carboxyﬂuorescein
succinimidyl ester. Appl Environ Microbiol 62: 178–183.
Buck, B.L., Altermann, E., Svingerud, T., and Klaenhammer,
T.R. (2005) Functional analysis of putative adhesion fac-
tors in Lactobacillus acidophilus NCFM. Appl Environ
Microbiol 71: 8344–8351.
Buntin, N., Hongpattarakere, T., Ritari, J., Douillard, F.P., Pau-
lin, L., Boeren, S., et al. (2017) An inducible operon is
involved in inulin utilization in Lactobacillus plantarum
strains, as revealed by comparative proteogenomics and
metabolic proﬁling. Appl Environ Microbiol 83: e02402–16.
Chiron, C., Tompkins, T. A., and Burguiere, P. (2017) Flow
cytometry: a versatile technology for speciﬁc quantiﬁcation
and viability assessment of micro-organisms in multistrain
probiotic products. J Appl Microbiol 124: 572–584.
Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A.,
Olsen, J. V., and Mann, M. (2011) Andromeda: a peptide
search engine integrated into the maxquant environment.
J Prot Res 10: 1794–1805.
Davis, C. (2014) Enumeration of probiotic strains: review of
culture-dependent and alternative techniques to quantify
viable bacteria. J Microbiol Meth 103: 9–17.
De Almada, C.N., Almada, C.N., Martinez, R.C.R., and San-
t’Ana, A.S. (2016) Paraprobiotics: evidences on their abil-
ity to modify biological responses, inactivation methods
and perspectives on their application in foods. Trends
Food Sci Technol 58: 96–114.
Douillard, F.P., Mora, D., Eijlander, R.T., Wels, M., and de
Vos, W.M. (2018) Comparative genomic analysis of the
multispecies probiotic-marketed product VSL#3. PLoS
One 13: e0192452.
Drago, L., Rodighiero, V., Celeste, T., Rovetto, L., and de
Vecchi, E. (2010) Microbiological evaluation of commer-
cial probiotic products available in the USA in 2009. J
Chemother 22: 373–377.
Edwards-Ingram, L., Gitsham, P., Burton, N., Warhurst, G.,
Clarke, I., Hoyle, D., et al. (2007) Genotypic and physio-
logical characterization of Saccharomyces boulardii, the
ª 2019 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology., Microbial
Biotechnology, 12, 1371–1386
1384 D. Mora et al.
probiotic strain of Saccharomyces cerevisiae. Appl Envi-
ron Microbiol 73: 2458–2467.
EFSA Panel on Dietetic Products, Nutrition and Allergies.
(2010) Scientiﬁc Opinion on the substantiation of health
claims related to live yoghurt cultures and improved lac-
tose digestion (ID 1143, 2976) pursuant to Article 13(1) of
Regulation (EC) No 1924/2006. EFSA J 8: 1763.
Garrigues, C., Johansen, E., and Pedersen, M.B. (2010)
Complete genome sequence of Biﬁdobacterium animalis
subsp. lactis BB-12, a widely consumed probiotic strain. J
Bacteriol 192: 2467–2468.
Gueimonde, M., Florez, A.B., van Hoek, A.H., Stuer-Laurid-
sen, B., Stroman, P., de los Reyes-Gavilan, C. G, and
Margolles, A. (2010) Genetic basis of tetracycline resis-
tance in Biﬁdobacterium animalis subsp. lactis. Appl Envi-
ron Microbiol 76: 3364–3369.
Gunasekera, T.S., Veal, D.A., and Attﬁeld, P.V. (2003)
Potential for broad applications of ﬂow cytometry and ﬂuo-
rescence techniques in microbiological and somatic cell
analyses of milk. Int J Food Microbiol 85: 269–279.
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein,
D.J., Pot, B., et al. (2014) The International Scientiﬁc
Association for Probiotics and Prebiotics consensus state-
ment on the scope and appropriate use of the term probi-
otic. Nat Rev Gastr Hepat 11: 506–514.
Ibrahim, S.A., and Carr, J.P. (2006) Viability of biﬁdobacteria
in commercial yogurt products in North Carolina. Int J
Dairy Tech 59: 272–277.
ISO/IDF (2010) Milk products-enumeration of presumptive
biﬁdobacteria-colony count technique at 37°C. ISO Stan-
dard 29981/IDF 220: 2010.
Jackson, S.A., Schoeni, J.L., Vegge, C., Pane, M., Stahl,
B., Bradley, M., et al. (2019) Improving end-user trust in
the quality of commercial probiotic products. Front Micro-
biol 10: 739.
Kankainen, M., Paulin, L., Tynkkynen, S., von Ossowski, I.,
Reunanen, J., Partanen, P., et al. (2009) Comparative
genomic analysis of Lactobacillus rhamnosus GG reveals
pili containing a human- mucus binding protein. Proc Natl
Acad Sci USA 106: 17193–17198.
Klaassens, E.S., de Vos, W.M., and Vaughan, E.E. (2007)
A metaproteomics approach to study the functionality of
the microbiota in the human infant gastrointestinal tract.
Appl Environ Microbiol 73: 1388–1392.
Kleerebezem, M., Boekhorst, J., van Kranenburg, R., Mole-
naar, D., Kuipers, O.P., Leer, R., et al. (2003) Complete
genome sequence of Lactobacillus plantarum WCFS1.
Proc Natl Acad Sci USA 100: 1990–1995.
Klotz, C., and Barrangou, R. (2018) Engineering compo-
nents of the Lactobacillus S-layer for biotherapeutic appli-
cations. Frontiers in Microbiol 9: 2264.
Kolace^k, S., Hisak, I., Berni Canani, R., Guarino, A., Indrio,
F., Orel, R., et al. (2017) Commercial probiotic products:
a call for improved quality control. a position paper by the
ESPGHAN working group for probiotics and prebiotics. J.
Pediatr Gastroenterol Nutr 65: 117–124.
Kolmeder, C.A., and de Vos, W.M. (2014) Metaproteomics of
our microbiome – developing insight in function and activity
in man and model systems. J Proteomics 97: 3–16.
Kolmeder, C.A., Ritari, J., Verdam, F.J., Muth, T., Keskitalo,
S., Varjosalo, M., et al. (2015) Colonic metaproteomic
signatures of active bacteria and the host in obesity. Pro-
teomics 15: 3544–52.
Kolmeder, C.A., Saloj€arvi, J., Ritari, J., de Been, M., Raes,
J., Falony, G., et al. (2016) Faecal metaproteomic analy-
sis reveals a personalized and stable functional micro-
biome and limited effects of a probiotic intervention in
adults. PLoS One 11: e0153294.
Konstantinov, S., Smidt, H., de Vos, W., Bruijns, S.C.M.,
Singh, S.K., Valence, F., et al. (2008) S layer protein A of
Lactobacillus acidophilus NCFM regulates immature den-
dritic cell and T cell functions. Proc Natl Acad Sci USA
105: 19474–19479.
Kramer, M., Obermajer, N., Bogovic Matijasic, B., Rogelj, I.,
and Kmetec, V. (2009) Quantiﬁcation of live and dead
probiotic bacteria in lyophilised product by real-time PCR
and by ﬂow cytometry. Appl Microbiol Biotechnol 84:
1137–1147.
Krishnan, S., Gowda, L.R., and Karanth, N.G. (2000) Stud-
ies on lactate dehydrogenase of Lactobacillus plantarum
spp. involved in lactic acid biosynthesis using perme-
abilised cells. Proc Biochem 35: 1191–1198.
Li, D., Liu, C.M., Luo, R., Sadakane, K., and Lam, T.W.
(2015) MEGAHIT: an ultra-fast single-node solution for
large and complex metagenomics assembly via succinct
de Bruijn graph. Bioinformatics 31: 1674–1676.
Lin, W.-H., Hwang, C.-F., Chen, L.-W., and Tsen, H.-Y. (2006)
Viable counts, characteristic evaluation for commercial lactic
acid bacteria products. Food Microbiol 23: 74–81.
Lo Cascio, R.G., Desai, P., Sela, D.A., Weimer, B., and
Mills, D.A. (2010) Broad conservation of milk utilization
genes in Biﬁdobacterium longum subsp. infantis as
revealed by comparative genomic hybridization. Appl
Environ Microbiol 76: 7373–7381.
Lugli, G. A., Mangifesta, M., Mancabelli, L., Milani, C., Tur-
roni, F., Viappani, A., et al. (2019) Compositional assess-
ment of bacterial communities in probiotic supplements by
means of metagenomic techniques. Int J Food Microbiol
294: 1–9.
Magoc, T., and Salzberg, S.L. (2011) FLASH: fast length
adjustment of short reads to improve genome assemblies.
Bioinformatics 27: 2957–2963.
Marco, M. L., and Tachon, S. (2013) Environmental factors
inﬂuencing the efﬁcacy of probiotic bacteria. Cur Opin
Biotechnol 24: 207–213.
McArthur, A. G., Waglechner, N., Nizam, F., Yan, A., Azad,
M.A., Baylay, A.J., et al. (2013) The comprehensive
antibiotic resistance database. Antimicrob Agents Che-
mother 57: 3348–3357.
Milani, C., Duranti, S., Lugli, G.A., Bottacini, F., Strati, F.,
Arioli, S., et al. (2013) Comparative genomics of Biﬁ-
dobacterium animalis subsp. lactis reveals a strict mono-
phyletic biﬁdobacterial taxon. Appl. Environ. Microbiol 79:
4304–4315.
Millward, D.J., Forrester, T., Ah-Sing, E., Yeboah, N., Gib-
son, N., Badaloo, A., et al. (2000) The transfer of 15N
from urea to lysine in the human infant. British J Nut 83:
505–512.
Mora, D., and Arioli, S. (2014) Microbial urease in health
and disease. PLoS Pathog 10: e1004472.
Mora, D., Maguin, E., Masiero, M., Parini, C., Ricci, G.,
Manachini, P. L., et al. (2004) Characterization of urease
ª 2019 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology., Microbial
Biotechnology, 12, 1371–1386
Omics-based microbiological control for probiotics 1385
genes cluster of Streptococcus thermophilus. J Appl
Microbiol 96: 209–219.
Mora, D., Monnet, C., Parini, C., Guglielmetti, S., Mariani,
A., Pintus, P., et al. (2005) Urease biogenesis in Strepto-
coccus thermophilus. Res Microbiol 156: 897–903.
Morovic, W., Hibberd, A.A., Zabel, B., Barrangou, R., and
Sthal, B. (2016) Genotyping by PCR and high-throughput
sequencing of commercial probiotic products reveals com-
position biases. Front Microbiol 7: 1747.
Muto, M., Abe, F., Yaeshima, T., and Iwatsuki, K. (2010)
Effect of enumeration method on Biﬁdobacterium cell
counts in commercial powder products. Biosci Microﬂora
29: 143–148.
O’Connell Motherway, M., Zomer, A., Leahy, S.C., Reuna-
nen, J., Bottacini, F., Claesson, M. J., et al. (2011) Func-
tional genome analysis of Biﬁdobacterium breve
UCC2003 reveals type IVb tight adherence (Tad) pili as
an essential and conserved host-colonization factor. Proc
Natl Acad Sci USA 108: 11217–11222.
Oberg, T.S., Steele, J.L., Ingham, S.C., Smeianov, V.V.,
Briczinski, E.P., Abdalla, A., et al. (2011) Intrinsic and
inducible resistance to hydrogen peroxide in Biﬁdobac-
terium species. J Ind Microbiol Biotechnol 38: 1947–1953.
Oberg, T.S., Ward, R.E., Steele, J.L., and Broadbent, J.R.
(2013) Genetic and physiological responses of Biﬁdobac-
terium animalis subsp. lactis to hydrogen peroxide stress.
J Bacteriol 195: 3743–3751.
Oosterkamp, M.J., Boeren, S., Plugge, C.M., Schaap, P.J.,
and Stams, A.J.M. (2013) Metabolic response of Alicy-
cliphilus denitriﬁcans strain BC toward electron acceptor
variation. Proteomics 13: 2886–2894.
Patrone, V., Molinari, P., and Morelli, L. (2016) Microbiologi-
cal and molecular characterization of commercially avail-
able probiotics containing Bacillus clausii from India and
Pakistan. Int. J. Food Microbiol 237: 92–97.
Power, D.A., Burton, J.P., Chilcott, C.N., Dawes, P.J., and
Tagg, J.R. (2008) Preliminary investigations of the coloniza-
tion of upper respiratory tract tissues of infants using a pedi-
atric formulation of the oral probiotic Streptococcus
salivarius K12. Eur J Clin Microbiol Infect Dis 27: 1261–
1263.
Rada, V., and Koc, J. (2000) The use of mupirocin for
selective enumeration of biﬁdobacteria in fermented milk
products. Milchwissenschaft 55: 65–67.
Rigottier-Gois, L., Le Bourhis, A.-G., Gramet, G., Rochet,
V., and Dore, J. (2003) Fluorescent hybridisation com-
bined with ﬂow cytometry and hybridisation of total RNA
to analyse the composition of microbial communities in
human faeces using 16S rRNA probes. FEMS Microbiol
Ecol 43: 237–245.
Sanders, M.E., Klaenhammer, T., Ouwehand, A.C., Pot, B.,
Johansen, E., Heimbach, J.T., et al. (2014) Effects of
genetic, processing, or product formulation changes on
efﬁcacy and safety of probiotics. Ann N Y Acad Sci 13:
1–18.
Sawatari, Y., and Yokota, A. (2007) Diversity and mecha-
nisms of alkali tolerance in Lactobacilli. Appl Environ
Microbiol 73: 3909–3915.
Sincock, S.A., and Robinson, J.P. (2001) Flow cytometric
analysis of microorganisms. Meth Cell Biol 64: 511–537.
Solopova, A., van Gestel, J., Weissing, F.J., Bachmann, H.,
Teusink, B., Kok, J., et al. (2014) Bet-hedging during bacte-
rial diauxic shift. Proc Natl Acad Sci USA 111: 7427–7432.
Taverniti, V., and Guglielmetti, S. (2011) The immunomodu-
latory properties of probiotic microorganisms beyond their
viability (ghost probiotics: proposal of paraprobiotic con-
cept). Genes Nutr 6: 261–274.
Taverniti, V., Stuknyte, M., Minuzzo, M., Arioli, S., De Noni,
I., Scabiosi, C., et al. (2013) S-layer protein mediates the
stimulatory effect of Lactobacillus helveticus MIMLh5 on
innate immunity. Appl Environ Microbiol 79: 1221–1231.
Teusink, B., Bachmann, H., and Molenaar, D. (2011) Sys-
tems biology of lactic acid bacteria: a critical review.
Microbial Cell Fact 10(Suppl 1): S11.
Tumuola, E., Crittenden, R., Playne, M., Isolauri, E., and
Salminen, S. (2001) Quality assurance criteria for probi-
otic bacteria. Am J Clin Nutr 73(suppl): 393S–398s.
Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M.
Y., Geiger, T., et al. (2016) The Perseus computational
platform for comprehensive analysis of (prote)omics data.
Nat Methods 13: 731–740.
Van den Bogaard, P.T.C., Kleerebezem, M., Kuipers, O.P.,
and de Vos, W. (2000) Control of lactose transport, b-galac-
tosidase activity, and glycolysis by CcpA in Streptococcus
thermophilus: evidence for carbon catabolite repression by
a non-phosphoenolpyruvate-dependent phosphotransferase
system sugar. Appl Environm Microbiol 182: 5982–5989.
Vecchione, A., Francesco, C., Mazzantini, D., Senesi, S.,
Lupetti, A., and Ghelardi, E. (2018) Compositional Quality
and Potential Gastrointestinal Behavior of Probiotic Prod-
ucts Commercialized in Italy. Front Med 5: 59.
Wilkinson, M. G. (2018) Flow cytometry as a potential
method of measuring bacterial viability in probiotic prod-
ucts: a review. Trends Food Sci Technol. 78: 1–10.
Wilson, C.M., Loach, D., Lawley, B., Bell, T., Sims, I.M.,
O’Toole, P.W., et al. (2014) Lactobacillus reuteri 100–23
modulates urea hydrolysis in the murine stomach. Appl
Environ Microbiol 80: 6104–6113.
Yatsunenko, T., Rey, F.E., Manary, M., Trehan, I., Domin-
guez-Bello, M.G., Contreras,M., et al. (2012) Human gut
microbiome viewed across age and geography. Nature
486: 222–227.
Supporting information
Additional supporting information may be found online
in the Supporting Information section at the end of the
article.
Fig. S1. qPCR calibration curves for each VSL#3 species.
Ct values vs. Log10 FU is repeated together with the linear
regression line equation and tge R2 value. The code of the
VSL#3 strains used to build the calibration curves is
repeated. FU, Flouorescence Units because cells have
been counted by ﬂow cytometry.
Table S1. Species-speciﬁc primers targeted to the pyrK
gene of VSL#3 species.
Table S2. Differentially abundant protein species detected
by metaproteomics in VSL#3 lots B and C.
ª 2019 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology., Microbial
Biotechnology, 12, 1371–1386
1386 D. Mora et al.
